Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruhisa Iguchi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Application of microRNAs to Cancer Therapy]Haruhisa Iguchi, Takahiro Ochiya
Cancer Science|July 14, 2010
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosisNobuyoshi Kosaka, Haruhisa Iguchi, Takahiro Ochiya
Current Drug Discovery Technologies|September 15, 2010
Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkersHaruhisa Iguchi, Nobuyoshi Kosaka, Takahiro Ochiya
Communicative & Integrative Biology|November 9, 2010
Secretory microRNAs as a versatile communication toolHaruhisa Iguchi, Nobuyoshi Kosaka, Takahiro Ochiya
The Journal of Biological Chemistry|November 30, 2011
Competitive interactions of cancer cells and normal cells via secretory microRNAsNobuyoshi Kosaka, Haruhisa Iguchi, Yusuke Yoshioka, et al.
The Journal of Biological Chemistry|February 27, 2013
Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasisNobuyoshi Kosaka, Haruhisa Iguchi, Keitaro Hagiwara, et al.
The Journal of Biological Chemistry|April 1, 2010
Secretory mechanisms and intercellular transfer of microRNAs in living cellsNobuyoshi Kosaka, Haruhisa Iguchi, Yusuke Yoshioka, et al.
Molecular Cancer Research : MCR|May 3, 2019
Evaluation of Tumor Cell-Tumor Microenvironment Component Interactions as Potential Predictors of Patient Response to NapabucasinAn-Yun Chang, Eric Hsu, Jaimin Patel, et al.
Biochemical and Biophysical Research Communications|March 17, 2004
USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidneyMotoko Yanagita, Masako Oka, Tetsuro Watabe, et al.
The Journal of Biological Chemistry|April 7, 2007
SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferationHaruhisa Iguchi, Yasuyo Urashima, Yosuke Inagaki, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Application of microRNAs to Cancer Therapy]Haruhisa Iguchi, Takahiro Ochiya
Cancer Science|July 14, 2010
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosisNobuyoshi Kosaka, Haruhisa Iguchi, Takahiro Ochiya
Current Drug Discovery Technologies|September 15, 2010
Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkersHaruhisa Iguchi, Nobuyoshi Kosaka, Takahiro Ochiya
Communicative & Integrative Biology|November 9, 2010
Secretory microRNAs as a versatile communication toolHaruhisa Iguchi, Nobuyoshi Kosaka, Takahiro Ochiya
The Journal of Biological Chemistry|November 30, 2011
Competitive interactions of cancer cells and normal cells via secretory microRNAsNobuyoshi Kosaka, Haruhisa Iguchi, Yusuke Yoshioka, et al.
The Journal of Biological Chemistry|February 27, 2013
Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasisNobuyoshi Kosaka, Haruhisa Iguchi, Keitaro Hagiwara, et al.
The Journal of Biological Chemistry|April 1, 2010
Secretory mechanisms and intercellular transfer of microRNAs in living cellsNobuyoshi Kosaka, Haruhisa Iguchi, Yusuke Yoshioka, et al.
Molecular Cancer Research : MCR|May 3, 2019
Evaluation of Tumor Cell-Tumor Microenvironment Component Interactions as Potential Predictors of Patient Response to NapabucasinAn-Yun Chang, Eric Hsu, Jaimin Patel, et al.
Biochemical and Biophysical Research Communications|March 17, 2004
USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidneyMotoko Yanagita, Masako Oka, Tetsuro Watabe, et al.
The Journal of Biological Chemistry|April 7, 2007
SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferationHaruhisa Iguchi, Yasuyo Urashima, Yosuke Inagaki, et al.
Pageof 2